IeDEA Consortium publishes journal supplement on research priorities for achieving universal HIV treatment in sub-Saharan Africa

Nearly all countries in sub-Saharan Africa (SSA) have adopted national polices for universal HIV treatment, regardless of CD4 cell count or clinical stage. Evidence to date from SSA suggests that, once linked to care, timely ART initiation with retention and viral suppression is the norm. However, ART initiation in SSA usually occurs late in the course of infection, driving up mortality and new infection rates. With 10.3 million people untreated and a projected 1.2M new infections per year in SSA, the universal treatment era presents strategic opportunities for health systems to substantially reduce AIDS-related mortality and HIV incidence. This special issue of the Journal of Virus Eradication, with contributing authors from the African regions of the IeDEA consortium and the World Health Organization (WHO), contains an editorial and eight articles focused on issues critical to ensuring the success and impact of universal treatment implementation in SSA.

For the complete edition and all articles click here

Adherence 2019 – Registration and abstract submission now open

Adherence 2019 will take place June 17-19, 2019, at the Loews Miami Beach Hotel in Miami, FL, USA. Sponsored by the International Association of Providers of AIDS Care (IAPAC), this annual series of conferences features the presentation and discussion of HIV treatment and biomedical prevention adherence research, and current behavioral and clinical perspectives in practicum, within the context of optimizing the continuum of HIV care and prevention. Adherence 2019 will also feature an implementation science track focused on closing gaps between evidence and routine practice for health in real-world settings.

For more information and registration/abstract submission please click here

12th INTEREST Conference

29 May – 1 June 2018, Kigali, Rwanda

The 12th INTEREST Conference (known as the ‘African CROI’) will take place from 29 May – 1 June 2018 in Kigali, Rwanda.  The Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission.  Continue reading “12th INTEREST Conference”